Related Experiment Videos
Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids
Clinical and Experimental Immunology
|June 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High-pressure, high-temperature molecular doping of nanodiamond.
Science advances·2019
The nature, origin and modification of insoluble organic matter in chondrites, the possibly interstellar source of Earth's C and N.
Chemie der Erde : Beitrage zur chemischen Mineralogie, Petrographie und Geologie·2019
From amorphous to nanocrystalline: the effect of nanograins in an amorphous matrix on the thermal conductivity of hot-wire chemical-vapor deposited silicon films.
Journal of physics. Condensed matter : an Institute of Physics journal·2017
Severe haemophilia A patients have reduced numbers of peripheral memory B cells.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
Vasculitis in association with australia antigen.
The Journal of experimental medicine·2009
Dysregulated complement activation in COVID-19: The Role of Soluble Complement Inhibitors.
Clinical and experimental immunology·2026
Diagnosing primary immunodeficiencies using protein-based screening assays.
Clinical and experimental immunology·2026
Precision targeting and alternative effector cells: Revolutionizing CAR-based therapy for T-cell malignancies.
Clinical and experimental immunology·2026
Selinexor potentiates NK cell activation against multiple myeloma.
Clinical and experimental immunology·2026
Management of hereditary angioedema in the UK: a comparison with international guidelines.
Clinical and experimental immunology·2026
Clinical and radiological comparisons of posterior labral tears with and without posterior glenohumeral instability.
Clinics in shoulder and elbow·2026
Analysis of serological markers and synovial fluid cytology in aseptic revision total knee arthroplasty.
Archives of orthopaedic and trauma surgery·2026
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double-Blind, Placebo-Controlled APEX Study.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Sema4A neutralization reduces fibrosis and inflammation in a mouse model of systemic sclerosis and a 3D model of immunity-driven fibrosis.
Arthritis & rheumatology (Hoboken, N.J.)·2026